Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[Deflazacort]1件: Deflazacort (Deflazacort)1件: Deflazacort (Deflazacort, DEFLAZACORT ORAL SUSPENSION) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
2Behavioral: Duchenne Muscular Dystrophy group with Deflazacort1件: Deflazacort (Deflazacort)1件: Deflazacort (Deflazacort, DEFLAZACORT ORAL SUSPENSION) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
3Deflazacort1件: Deflazacort (Deflazacort)1件: Deflazacort (Deflazacort, DEFLAZACORT ORAL SUSPENSION) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 30, 113 💬
4Deflazacort 6 mg Tablets1件: Deflazacort (Deflazacort)1件: Deflazacort (Deflazacort, DEFLAZACORT ORAL SUSPENSION) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
5EMFLAZA® (DEFLAZACORT)1件: Deflazacort (Deflazacort)1件: Deflazacort (Deflazacort, DEFLAZACORT ORAL SUSPENSION) 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬